Andrea Vismara
Vermogen: 14 M $ op 31-05-2026
Vermogen: 14 M $ op 31-05-2026
Andrea Vismara is Chief Executive Officer at Equita SIM SpA since 2017.
Mr. Vismara is Chief Executive Officer & Director at Equita Group SpA since 2008.
Mr. Vismara is Director at Blue Earth Diagnostics Ltd. Mr. Vismara is Director at Blue Earth Therapeutics Ltd. since 2022.
Mr. Vismara is Member at Commissione Nazionale per le Società e la Borsa.
Mr. Vismara is President at Equita Sim SpA (Investment Management) starting 2026.
Former roles include Vice Chairman at Assosim Associazione Italiana Intermediari Mobiliari and Chief Operating Officer at Credit Suisse First Boston Italia SpA from 2002 to 2003.
Education includes graduate degree from New York University and undergraduate degree from the University of Bocconi.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
EQUITA GROUP SPA 3,94% | 31-07-2025 | 2.101.734 ( 3,94% ) | 14 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| EQUITA GROUP S.P.A. | Algemeen Directeur | - |
Equita SIM SpA
Equita SIM SpA Investment Banks/BrokersFinance Provides brokerage services | Algemeen Directeur | 01-07-2017 |
Equita Sim SpA (Investment Management)
Equita Sim SpA (Investment Management) Investment ManagersFinance Equita Sim-IM is mainly focused on alternative, illiquid strategies in the Italian market with a focus on mid and small-caps. | President | 01-01-2026 |
Commissione Nazionale per le Società e la Borsa
Commissione Nazionale per le Società e la Borsa General GovernmentGovernment Regulation of public savings | Corporate Officer/Principal | - |
Blue Earth Diagnostics Ltd.
Blue Earth Diagnostics Ltd. Medical/Nursing ServicesHealth Services Develops and commercialization molecular imaging technologies | Directeur/Bestuurslid | - |
Blue Earth Therapeutics Ltd.
Blue Earth Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company that develops radiopharmaceuticals and oncology drugs | Directeur/Bestuurslid | - |
| Bedrijven | Functie | Einde |
|---|---|---|
Credit Suisse First Boston Italia SpA
Credit Suisse First Boston Italia SpA Investment Banks/BrokersFinance Provides securities, investment banking, insurance, investment trust, and management services | Operationeel Directeur | 01-01-2003 |
Assosim Associazione Italiana Intermediari Mobiliari | Directeur/Bestuurslid | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 10 |
|---|---|
Equita SIM SpA
Equita SIM SpA Investment Banks/BrokersFinance Provides brokerage services | Finance |
New York University
New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Bocconi
University of Bocconi Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Credit Suisse First Boston Italia SpA
Credit Suisse First Boston Italia SpA Investment Banks/BrokersFinance Provides securities, investment banking, insurance, investment trust, and management services | Finance |
Commissione Nazionale per le Società e la Borsa
Commissione Nazionale per le Società e la Borsa General GovernmentGovernment Regulation of public savings | Government |
Assosim Associazione Italiana Intermediari Mobiliari | |
Equita Sim SpA (Investment Management)
Equita Sim SpA (Investment Management) Investment ManagersFinance Equita Sim-IM is mainly focused on alternative, illiquid strategies in the Italian market with a focus on mid and small-caps. | Finance |
Blue Earth Diagnostics Ltd.
Blue Earth Diagnostics Ltd. Medical/Nursing ServicesHealth Services Develops and commercialization molecular imaging technologies | Health Services |
Equita Group SpA
Equita Group SpA Investment Banks/BrokersFinance Operates as holding company whose subsidiary provides investment banking services | Finance |
Blue Earth Therapeutics Ltd.
Blue Earth Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company that develops radiopharmaceuticals and oncology drugs | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau